GlassScriptPhysician profile
Kevin G Nickell
NPI 1053388785
$18,448.64
in general payments reported to CMS, 2019-2025
54 companies · $8,001 in 2025
The $8,001 reported for 2025 was more than what 93% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,882 · 2020: $1,182 · 2021: $1,207 · 2022: $1,756 · 2023: $1,980 · 2024: $2,441 · 2025: $8,001.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,279 · Long Term Medical Supply Or Device Loan: $5,143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,279.26 |
| Long Term Medical Supply Or Device Loan | $5,142.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hmu Consumables, LLC | $5,142.85 | 2025 | Dornier Medtech |
| Boston Scientific Corporation | $2,243.35 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700, Rezum Generator |
| Pfizer INC. | $996.13 | 2019-2025 | |
| Coloplast Corp | $976.52 | 2019-2024 | Altis, Coloplast Tfl Drive |
| Sumitomo Pharma America, INC. | $742.40 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $736.79 | 2019-2025 | Xtandi, Padcev |
| Janssen Biotech, INC. | $674.23 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Myriad Genetic Laboratories, INC. | $669.74 | 2020-2025 | Prolaris |
| Dendreon Pharmaceuticals LLC | $476.33 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $426.58 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $417.81 | 2019-2023 | Xiaflex, Aveed |
| Antares Pharma, INC. | $379.04 | 2020-2025 | Xyosted, Tlando, Nocdurna |
| Ferring Pharmaceuticals INC. | $372.62 | 2019-2025 | Adstiladrin |
| Abbvie INC. | $318.74 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $310.62 | 2020-2025 | Keytruda, Lynparza, Keytruda Qlex |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $263.96 | 2023-2025 | Jatenzo, Eligard |
| Progenics Pharmaceuticals, INC. | $246.14 | 2023-2025 | Pylarify |
| C. R. Bard, INC. & Subsidiaries | $223.92 | 2022-2025 | Aptra, Bard Urinary Drainage Bag |
| Medtronic, INC. | $220.67 | 2024 | Interstim |
| Procept Biorobotics Corporation | $215.38 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
| Allergan, INC. | $205.85 | 2019-2022 | |
| Convatec INC. | $193.13 | 2022-2024 | |
| 180 Medical, INC. | $186.84 | 2019-2025 | |
| Myovant Sciences INC. | $169.61 | 2021-2022 | |
| Neotract INC. | $164.35 | 2020 | |
| Biotissue Holdings INC. | $121.85 | 2024-2025 | |
| Aytu Biopharma, INC. | $115.01 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $96.94 | 2022 | |
| Travere Therapeutics, INC. | $87.66 | 2019-2021 | |
| Abc Home Medical Supply, INC. | $85.28 | 2024 | |
| Urogen Pharma, INC. | $73.42 | 2023-2025 | Jelmyto |
| Endo USA, INC. | $70.85 | 2024-2025 | Aveed, Xiaflex |
| Axonics, INC. | $69.42 | 2020 | |
| Immunitybio, INC. | $64.32 | 2024 | |
| Teleflex LLC | $59.14 | 2019-2023 | Urolift |
| Novartis Pharmaceuticals Corporation | $51.31 | 2025 | |
| Verity Pharmaceuticals INC. | $50.36 | 2023-2025 | Trelstar |
| Healthtronics Stone Solutions, LLC | $48.54 | 2024 | Dornier Medtech |
| Accord Healthcare, INC. | $48.25 | 2023 | |
| Ambu INC. | $48.13 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $46.09 | 2023 | Lynparza |
| Halozyme INC | $40.78 | 2023 | |
| Telix Pharmaceuticals | $38.94 | 2023-2024 | Illuccix |
| Blue Earth Diagnostics | $38.02 | 2019-2022 | |
| Acerus Pharmaceuticals Corporation | $33.83 | 2020-2022 | |
| Amgen INC. | $33.28 | 2019 | |
| Cook Medical LLC | $29.47 | 2024 | Ncircle |
| Baxter Healthcare | $25.39 | 2023 | Tisseel |
| Rochester Medical Corporation | $22.28 | 2022 | |
| Avanos Medical | $19.00 | 2023 | On-Q* Pump and Accessories |
| Ethicon US, LLC | $18.21 | 2019 | |
| Azurity Pharmaceuticals, INC. | $16.99 | 2025 | Azmiro |
| Clarus Therapeutics INC. | $13.74 | 2021 | |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$14,814.84 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Nickell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.